See something missing? Fill out this form to add your event.
FDA Workshop – Advancing Pediatric Cell and Gene Therapy Clinical Trials: Scientific, Ethical, Regulatory, and Practical Considerations
- This event has passed.
April 9 @ 9:00 am – 4:30 pm EDT
In Person or Virtual Workshop!
The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) and the Alliance for Regenerative Medicine (ARM) are co-hosting a hybrid workshop on April 9, 2026, titled “Advancing Pediatric Cell and Gene Therapy Clinical Trials.” The workshop will explore the issues surrounding clinical trials for cell and gene therapies (CGTs) in pediatric populations, particularly for diseases where earlier intervention may result in greater therapeutic benefit. This includes conditions that affect both pediatric and adult populations, as well as diseases that occur primarily in children.
Who should attend:
This workshop is open to the public and is intended for clinicians, scientists, bioethicists, academic and industry representatives, patients, caregivers, and their advocates.
